Cargando…

Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar

INTRODUCTION: Over half of those hepatitis C virus (HCV)/HIV coinfected live in low-income and middle-income countries, and many remain undiagnosed or untreated. In 2016, Médecins Sans Frontières (MSF) established a direct-acting antiviral (DAA) treatment programme for people HCV/HIV coinfected in M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marquez, Lara K, Chaillon, Antoine, Soe, Kyi Pyar, Johnson, Derek C, Zosso, Jean-Marc, Incerti, Andrea, Loarec, Anne, Nguyen, Aude, Walker, Josephine G, Mafirakureva, Nyashadzaishe, Lo Re III, Vincent, Wynn, Adriane, McIntosh, Craig, Kiene, Susan M, Brodine, Stephanie, Garfein, Richard S, Vickerman, Peter, Martin, Natasha K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908309/ https://www.ncbi.nlm.nih.gov/pubmed/33627360 http://dx.doi.org/10.1136/bmjgh-2020-004181

Ejemplares similares

Epidemiological characteristics and real‐world treatment outcomes of hepatitis C among HIV/HCV co‐infected patients in Myanmar: A prospective cohort study
por: Swe, Thein Min, et al.
Publicado: (2023)

Cost‐effectiveness of screening and treatment using direct‐acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan
por: Mafirakureva, Nyashadzaishe, et al.
Publicado: (2020)

Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis
por: McCombe, Geoff, et al.
Publicado: (2022)

The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study
por: Dodd, Peter J, et al.
Publicado: (2022)

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection
por: Chaillon, Antoine, et al.
Publicado: (2019)

Routine Immediate Eye Examination at the Point of Care for Diagnosis of AIDS-Related Cytomegalovirus Retinitis Among Patients With a CD4 Count <100 in Myanmar
por: Ei, Win Le Shwe Sin, et al.
Publicado: (2019)

Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data
por: Murray, Jillian, et al.
Publicado: (2020)

Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation
por: Killion, Jordan A., et al.
Publicado: (2023)

Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
por: Scott, Nick, et al.
Publicado: (2021)

Posttransplantation tuberculosis management in terms of immunosuppressant cost: a case report in Myanmar
por: Lwin, Phyo Wai, et al.
Publicado: (2021)

The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK
por: Ward, Zoe, et al.
Publicado: (2019)

Increased hepatitis C virus co-infection and injection drug use in HIV-infected fishermen in Myanmar
por: Ousley, Janet, et al.
Publicado: (2018)

Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study
por: Mafirakureva, Nyashadzaishe, et al.
Publicado: (2023)

Xpert Ultra stool testing to diagnose tuberculosis in children in Ethiopia and Indonesia: a model-based cost-effectiveness analysis
por: Mafirakureva, Nyashadzaishe, et al.
Publicado: (2022)

High levels of viral repression, malnutrition and second-line ART use in adolescents living with HIV: a mixed methods study from Myanmar
por: Murray, Jillian, et al.
Publicado: (2020)

Low Incidence of Renal Dysfunction among HIV-Infected Patients on a Tenofovir-Based First Line Antiretroviral Treatment Regimen in Myanmar
por: Kyaw, Nang Thu Thu, et al.
Publicado: (2015)

Treatment cost and costing model of obstetric complications at a hospital in Myanmar
por: Shwe, A. Thi Win, et al.
Publicado: (2019)

Measuring Catastrophic Costs Due to Tuberculosis in Myanmar
por: Aung, Si Thu, et al.
Publicado: (2021)

The first study on the prevalence of gastrointestinal parasites in owned and sheltered cats in Yangon, Myanmar
por: Soe, Babi Kyi, et al.
Publicado: (2023)

Cost estimates of COVID-19 clinical management in Myanmar
por: Thant, Phyu Win, et al.
Publicado: (2021)

Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar
por: Nyein, Phyo Pyae, et al.
Publicado: (2023)

Malaria incidence in Myanmar 2005–2014: steady but fragile progress towards elimination
por: Mu, Thet Thet, et al.
Publicado: (2016)

Geographical distribution of Burkholderia pseudomallei in soil in Myanmar
por: Swe, Myo Maung Maung, et al.
Publicado: (2021)

Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar
por: Win, Thin Mar, et al.
Publicado: (2023)

Clinical Profile of COVID-19 Patients Admitted at a Private Hospital During Three Surges in Mandalay, Myanmar
por: Kyu, Kyu, et al.
Publicado: (2023)

Cost of treating inpatient falciparum malaria on the Thai-Myanmar border
por: Kyaw, Shwe Sin, et al.
Publicado: (2014)

Malaria community health workers in Myanmar: a cost analysis
por: Kyaw, Shwe Sin, et al.
Publicado: (2016)

Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges
por: Dzingirai, Blessing, et al.
Publicado: (2021)

Masculinity and mental health treatment initiation for former political prisoners in Yangon, Myanmar – a qualitative investigation
por: Lakin, Daniel P., et al.
Publicado: (2021)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar
por: Kyaw, Shwe Sin, et al.
Publicado: (2021)

Presence of Burkholderia pseudomallei in the ‘Granary of Myanmar’
por: Win, Tun Tun, et al.
Publicado: (2019)

Modelling the impact and cost‐effectiveness of non‐governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine
por: Stone, Jack, et al.
Publicado: (2023)

Medical education in Myanmar: a critical commentary
por: Soe, Myo Min
Publicado: (2017)

Disaster preparedness and resilience at household level in Yangon, Myanmar
por: Heinkel, Sophie-Bo, et al.
Publicado: (2022)

Assessment of HIV testing among young methamphetamine users in Muse, Northern Shan State, Myanmar
por: Saw, Yu Mon, et al.
Publicado: (2014)

The clinical characteristics of adults with rheumatic heart disease in Yangon, Myanmar: An observational study
por: Myint, Nan Phyu Sin Toe, et al.
Publicado: (2018)

HIV care in Yangon, Myanmar; successes, challenges and implications for policy
por: Aung, Ne Myo, et al.
Publicado: (2017)

Clinical and laboratory parameters associated with acute kidney injury in patients with snakebite envenomation: a prospective observational study from Myanmar
por: Aye, Kyi-Phyu, et al.
Publicado: (2017)

The cost of service quality improvements: tracking the flow of funds in social franchise networks in Myanmar
por: Bishai, David, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j468vvle360141u0fg8o63o7te